| __timestamp | Supernus Pharmaceuticals, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 1802274 |
| Thursday, January 1, 2015 | 89204000 | 2512761 |
| Friday, January 1, 2016 | 106010000 | 2894488 |
| Sunday, January 1, 2017 | 137905000 | 8096274 |
| Monday, January 1, 2018 | 159888000 | 7985229 |
| Tuesday, January 1, 2019 | 158425000 | 8994597 |
| Wednesday, January 1, 2020 | 200677000 | 29772000 |
| Friday, January 1, 2021 | 304759000 | 33907000 |
| Saturday, January 1, 2022 | 377221000 | 26579000 |
| Sunday, January 1, 2023 | 336361000 | 49868547 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Supernus Pharmaceuticals, Inc. and Verona Pharma plc have taken different paths in optimizing these costs. From 2014 to 2023, Supernus Pharmaceuticals saw a staggering 364% increase in SG&A expenses, peaking in 2022. In contrast, Verona Pharma's expenses grew by approximately 2,667%, albeit from a much smaller base, reflecting its aggressive expansion strategy.
Supernus Pharmaceuticals, with its consistent growth, highlights a stable yet costly approach, while Verona Pharma's rapid increase suggests a focus on scaling operations. As the industry evolves, these strategies will play a pivotal role in determining market leadership. Investors and stakeholders should closely monitor these trends to gauge future performance and strategic direction.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of BioMarin Pharmaceutical Inc. and Verona Pharma plc
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Verona Pharma plc or MorphoSys AG
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.